Homozygosity of BACHD rats not only causes strong behavioral deficits in young female rats but also a reduced breeding success.

Behavioral analysis Breeding success Homozygosity Huntington’s disease Learning and memory Sex differences

Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
02 Mar 2021
Historique:
received: 15 10 2020
revised: 29 01 2021
accepted: 20 02 2021
pubmed: 5 3 2021
medline: 5 3 2021
entrez: 4 3 2021
Statut: aheadofprint

Résumé

Huntington's disease is known to be a purely genetic disease based on an expansion of a CAG base triplet repeat in the coding region of the Huntingtin gene. Some years ago, researchers were able to introduce the extensive full-length gene sequence of the mutant huntingtin gene into a rodent model. The resulting BACHD rat is already well characterized for behavioral deficits. So far, all analyses in this preclinical rat model were performed in male hemizygous animals. As homozygosity of transgenic models often causes an amplification of the phenotype and female HD patients present a stronger phenotype compared to men, we established a homozygous breeding colony and tested 2 and 5 months old homozygous male and female BACHD rats in a behavioral test battery. The tests included the grip strength test, Rota Rod, elevated plus maze, passive avoidance, and Barnes maze test. Our results show strong deficits in young female homozygous BACHD rats including increased body weight, motor deficits, muscle weakness, reduced anxiety and hypoactivity, as well as learning and memory deficits. Analysis of male homozygous BACHD rats showed only weak disease symptoms, similar compared to male hemizygous BACHD rats of already published studies. Evaluation of the breeding success showed that homozygous BACHD have a reduced number of pups at the time of birth that even decreases until weaning. Our results suggest that the phenotype of homozygous male BACHD rats barely differs from already published results of hemizygous BACHD rats while female homozygous BACHD rats display strong and early alterations.

Identifiants

pubmed: 33662341
pii: S0006-8993(21)00121-9
doi: 10.1016/j.brainres.2021.147396
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147396

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Stephan Kurat (S)

QPS Austria GmbH, Neuropharmacology, Parkring 12, 8074 Grambach, Austria. Electronic address: stephan.kurat@qps.com.

Petra Heinrich (P)

QPS Austria GmbH, Neuropharmacology, Parkring 12, 8074 Grambach, Austria. Electronic address: petra.heinrich@qps.com.

Agnes Molnar-Kasza (A)

QPS Austria GmbH, Neuropharmacology, Parkring 12, 8074 Grambach, Austria. Electronic address: agnes.molnar-kasza@qps.com.

Tina Loeffler (T)

QPS Austria GmbH, Neuropharmacology, Parkring 12, 8074 Grambach, Austria. Electronic address: tina.loeffler@qps.com.

Stefanie Flunkert (S)

QPS Austria GmbH, Neuropharmacology, Parkring 12, 8074 Grambach, Austria. Electronic address: stefanie.flunkert@qps.com.

Birgit Hutter-Paier (B)

QPS Austria GmbH, Neuropharmacology, Parkring 12, 8074 Grambach, Austria. Electronic address: birgit.hutter-paier@qps.com.

Classifications MeSH